Foamix Pharmaceuticals Ltd. (FOMX)

3.52
0.02 0.57
NASDAQ : Health Technology
Prev Close 3.50
Open 3.50
Day Low/High 3.40 / 3.57
52 Wk Low/High 1.97 / 7.60
Volume 452.65K
Avg Volume 681.80K
Exchange NASDAQ
Shares Outstanding 61.00M
Market Cap 208.63M
EPS -1.70
P/E Ratio 2.91
Div & Yield N.A. (N.A)
Foamix Reports Fiscal Year 2015 Financial Results And Provides Business Update

Foamix Reports Fiscal Year 2015 Financial Results And Provides Business Update

Conference Call and Webcast Today at 8:00am Eastern Time

Foamix Pharmaceuticals Enters Oversold Territory (FOMX)

Foamix Pharmaceuticals Enters Oversold Territory (FOMX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks trading for less than $10 a share look ready to trade higher from current levels.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABM, DD, DISH, ELTK, ERII, KELYB, SAIC, SLAB, SOHO, TER Downgrades: BBEP, BXE, CYH, EROS, ESCA, JNP, M, NRP, UUU, WYY Initiations: FOMX Read on to get TheStreet Quant Ratings' detailed report:

Foamix Reports Third Quarter 2015 Financial Results And Provides Business Update

Foamix Reports Third Quarter 2015 Financial Results And Provides Business Update

Conference Call and Webcast on Wednesday, November 11, 2015 at 8:00am Eastern / 5:00am Pacific

Foamix Reports Second Quarter 2015 Financial Results And Provides Business Update

Foamix Reports Second Quarter 2015 Financial Results And Provides Business Update

Conference Call and Webcast on Thursday, August 20, 2015 at 8:00am Eastern / 5:00am Pacific

MERZ North America Makes Milestone Payment To Foamix

MERZ North America Makes Milestone Payment To Foamix

Merz North America, Inc. and Foamix Pharmaceuticals Ltd.

Foamix Reports First Quarter Financial Results

Foamix Reports First Quarter Financial Results

Conference Call Begins on May 13, 2015 at 8:00am Eastern / 5:00am Pacific

Foamix Pharmaceuticals (FOMX) Stock Spiked Following Pricing of Upsized Offering

Foamix Pharmaceuticals (FOMX) Stock Spiked Following Pricing of Upsized Offering

Foamix Pharmaceuticals (FOMX) shares closed up double digits after the company announced the pricing of its upsized public offering.

TheStreet Quant Rating: D- (Sell)